Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 22, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- June 20, 2006: Transfer of 75,054 Ordinary Shares.
- June 21, 2006: Transfer of 7,592 Ordinary Shares.
These transactions were advised to the Company on June 22, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Investor Verification Points
- Confirm the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period (82,646 shares).
- Verify the identity of the directors with interests in the GSK Trust as disclosed.
- Note that this filing does not impact the Company's financial statements directly but reflects equity-based compensation activity.